Company intelligence / Profile preview

Progenetics

Tel Aviv, Tel Aviv District, Israellinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Progenetics is an Israeli company specializing in the distribution and marketing of advanced molecular diagnostic tests, particularly for oncology applications such as non-small cell lung cancer. The company partners with international firms to bring innovative liquid biopsy and tumor profiling technologies to the Israeli market.

Therapeutic areas: Oncology
Modalities: Diagnostic testMolecular diagnostics
Industry: Molecular Diagnostics

Partnerships

Biodesix (distribution of GeneStrat® and VeriStrat® liquid biopsy tests for NSCLC in Israel)

Beyond the preview

Go deeper on Progenetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progenetics.

Explore the full profile